These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 13680324)
1. Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience. Cesaro S; Strugo L; Alaggio R; Cecchetto G; Rigobello L; Pillon M; Cusinato R; Zanesco L Support Care Cancer; 2003 Nov; 11(11):722-7. PubMed ID: 13680324 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis. Cesaro S; Toffolutti T; Messina C; Calore E; Alaggio R; Cusinato R; Pillon M; Zanesco L Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338 [TBL] [Abstract][Full Text] [Related]
3. Successful treatment of invasive aspergillosis with oral voriconazole following intravenous liposomal amphotericin in a child with acute lymphoblastic leukemia. Lassaletta A; Perez A; Díaz MA; Sevilla J; González-Vicent M; Madero L J Pediatr Hematol Oncol; 2004 Feb; 26(2):117-9. PubMed ID: 14767202 [No Abstract] [Full Text] [Related]
4. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720 [TBL] [Abstract][Full Text] [Related]
5. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study. Mandhaniya S; Swaroop C; Thulkar S; Vishnubhatla S; Kabra SK; Xess I; Bakhshi S J Pediatr Hematol Oncol; 2011 Dec; 33(8):e333-41. PubMed ID: 22042283 [TBL] [Abstract][Full Text] [Related]
6. Case report: Invasive aspergillosis successfully treated with voriconazole without recurrence during subsequent bone marrow transplantation. Chow E; Moore T; Nielsen K Pediatr Infect Dis J; 2003 Dec; 22(12):1109-10. PubMed ID: 14688580 [TBL] [Abstract][Full Text] [Related]
7. Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant. Klein KC; Blackwood RA Pediatrics; 2006 Aug; 118(2):e506-8. PubMed ID: 16816005 [TBL] [Abstract][Full Text] [Related]
8. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Walsh TJ; Lutsar I; Driscoll T; Dupont B; Roden M; Ghahramani P; Hodges M; Groll AH; Perfect JR Pediatr Infect Dis J; 2002 Mar; 21(3):240-8. PubMed ID: 12005089 [TBL] [Abstract][Full Text] [Related]
9. Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation. Mattei D; Mordini N; Lo Nigro C; Ghirardo D; Ferrua MT; Osenda M; Gallamini A; Bacigalupo A; Viscoli C Bone Marrow Transplant; 2002 Dec; 30(12):967-70. PubMed ID: 12476292 [TBL] [Abstract][Full Text] [Related]
10. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature. Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575 [TBL] [Abstract][Full Text] [Related]
11. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed. Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210 [TBL] [Abstract][Full Text] [Related]
12. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis. Sambatakou H; Dupont B; Lode H; Denning DW Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972 [TBL] [Abstract][Full Text] [Related]
13. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B; N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683 [TBL] [Abstract][Full Text] [Related]
15. Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? Pagano L; Valentini CG; Fianchi L; Caira M J Chemother; 2011 Feb; 23(1):5-8. PubMed ID: 21482486 [TBL] [Abstract][Full Text] [Related]
16. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy]. Ozçelik T; Ozkalemkaş F; Kocaeli H; Altundal Y; Ener B; Ali R; Ozkocaman V; Hakyemez B; Tunali A Mikrobiyol Bul; 2009 Jul; 43(3):499-506. PubMed ID: 19795628 [TBL] [Abstract][Full Text] [Related]
17. Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion. Nosari A; Oreste P; Cairoli R; Montillo M; Carrafiello G; Astolfi A; Muti G; Marbello L; Tedeschi A; Magliano E; Morra E Am J Hematol; 2001 Dec; 68(4):231-6. PubMed ID: 11754411 [TBL] [Abstract][Full Text] [Related]
18. Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient. Damaj G; Ivanov V; Le Brigand B; D'incan E; Doglio MF; Bilger K; Faucher C; Vey N; Gastaut JA Ann Hematol; 2004 Jun; 83(6):390-3. PubMed ID: 14666380 [TBL] [Abstract][Full Text] [Related]
19. Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection. Klastersky J; Paesmans M Support Care Cancer; 2007 Feb; 15(2):137-41. PubMed ID: 16967301 [TBL] [Abstract][Full Text] [Related]
20. Treatment of disseminated aspergillosis with voriconazole/liposomal amphotericin B in a child with leukemia. Athanassiadou F; Tragiannidis A; Kourti M; Papageorgiou T; Velegraki A; Kalogera A Pediatr Blood Cancer; 2005 Dec; 45(7):1003-4. PubMed ID: 16047372 [No Abstract] [Full Text] [Related] [Next] [New Search]